KLRK1 and neoplasm: Adenomas (20% of Klrk1+/+ versus 23.5% of Klrk1−/−) and nodules (6.7% of Klrk1+/+ versus 5.9% of Klrk1−/−) accounted for the tumours in the remaining mice, with similar incidence levels in both genotypes (Fig. 1f, Supplementary Table 1).